Evidence map›Paper›PMID 32467232›Full record

ArticleThe Journal of biological chemistry2020

Role for carbohydrate response element-binding protein (ChREBP) in high glucose-mediated repression of long noncoding RNA Tug1.

Jianyin Long, Daniel L Galvan, Koki Mise, Yashpal S Kanwar, Li Li, Naravat Poungavrin, Paul A Overbeek, Benny H Chang, Farhad R Danesh

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. lncRNA TUG1 and kidney diseases.BMC nephrology · 2025
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Jianyin LongSection of Nephrology, Division of Internal Medicine, The University of Texas at MD Anderson Cancer Center, Houston, Texas, USA.
Daniel L GalvanSection of Nephrology, Division of Internal Medicine, The University of Texas at MD Anderson Cancer Center, Houston, Texas, USA.
Koki MiseSection of Nephrology, Division of Internal Medicine, The University of Texas at MD Anderson Cancer Center, Houston, Texas, USA; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Yashpal S KanwarDepartment of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Li LiSection of Nephrology, Division of Internal Medicine, The University of Texas at MD Anderson Cancer Center, Houston, Texas, USA; Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Naravat PoungavrinDepartment of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Paul A OverbeekDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.
Benny H ChangSection of Nephrology, Division of Internal Medicine, The University of Texas at MD Anderson Cancer Center, Houston, Texas, USA.
Farhad R DaneshSection of Nephrology, Division of Internal Medicine, The University of Texas at MD Anderson Cancer Center, Houston, Texas, USA; Department of Pharmacology & Chemical Biology, Baylor College of Medicine, Houston, Texas, USA. Electronic address: fdanesh@mdanderson.org.
The University of Texas MD Anderson Cancer Center · USBaylor College of Medicine · USNorthwestern University · USSiriraj Hospital · TH

Funding

Pathogenesis of Diabetic NephropathyR01DK060635 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI QUAGGIN, SUSAN E. · 2002 to 2023
$6.6M
MicroRNA In Diabetic NephropathyR01DK091310 · NIDDK · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DANESH, FARHAD R · 2011 to 2024
$5.3M
Role of Rho Kinases in Diabetic NephropathyR01DK078900 · NIDDK · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DANESH, FARHAD R · 2009 to 2024
$5.2M
REGULATION OF CYCLIN D1 EXPRESSION IN THE INTESTINER01DK060632 · NIDDK · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BLACK, JENNIFER D. · 2002 to 2014
$2.6M
NIDDK NIH HHS R01 DK060632NIDDK NIH HHS R01 DK060635NIDDK NIH HHS R01 DK078900NIDDK NIH HHS R01 DK091310
6 · The paper itself

Abstract

Long noncoding RNAs (lncRNAs) have been shown to play key roles in a variety of biological activities of the cell. However, less is known about how lncRNAs respond to environmental cues and what transcriptional mechanisms regulate their expression. Studies from our laboratory have shown that the lncRNA Tug1 (taurine upregulated gene 1) is crucial for the progression of diabetic kidney disease, a major microvascular complication of diabetes. Using a combination of proximity labeling with the engineered soybean ascorbate peroxidase (APEX2), ChIP-qPCR, biotin-labeled oligonucleotide pulldown, and classical promoter luciferase assays in kidney podocytes, we extend our initial observations in the current study and now provide a detailed analysis on a how high-glucose milieu downregulates Tug1 expression in podocytes. Our results revealed an essential role for the transcription factor carbohydrate response element binding protein (ChREBP) in controlling Tug1 transcription in the podocytes in response to increased glucose levels. Along with ChREBP, other coregulators, including MAX dimerization protein (MLX), MAX dimerization protein 1 (MXD1), and histone deacetylase 1 (HDAC1), were enriched at the

Indexed as

Gene Expression RegulationTranscription, GeneticAnimalsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCell Line, TumorGlucoseHistone Deacetylase 1HumansMicePodocytesRepressor ProteinsRNA, Long NoncodingBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsGlucoseHdac1 protein, mouseHistone Deacetylase 1long non-coding RNA TUG1, mouseMad protein, mouseMlxipl protein, mouseRepressor ProteinsRNA, Long NoncodingAPEX2carbohydrate response element-binding protein (ChREBP)ChREBPCRISPR/Casdiabetic nephropathyengineered soybean ascorbate peroxidase (APEX2)epigeneticsgene regulationkidneylong noncoding RNA (lncRNA)taurine upregulated gene 1 (Tug1)transcriptiontranscription regulationTug1

Identifiers

PMID32467232
PMCPMC7681008
OpenAlexW3031122910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.